赛升药业：关于公司及控股子公司使用部分闲置自有资金购买理财产品的公告

Core Viewpoint - The company announced the approval of a proposal to use idle funds for financial investments, indicating a strategic move to optimize asset utilization [1] Group 1 - The company plans to use up to 120,000 million yuan of its idle self-owned funds for investment in financial products [1] - The investment will be conducted by the company and its subsidiaries, ensuring that normal operations are not affected [1] - The investment period is valid for one year from the date of approval by the shareholders' meeting [1]